Extrathoracic mesothelial proliferations and their mimics

Ultrastructural Pathology

Volumn 30, Issue 1-2, 2006, Pages 37-51

  Lloreta Trull, Josep ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Electron microscopy; Immunohistochemistry; Mesothelioma; Mesothelium; Ovarian tumors; Peritoneal tumors; Serosal carcinoma; Serosal neoplasms; Testicular tumors

Indexed keywords

CA 19-9 ANTIGEN; CALRETININ; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; THROMBOMODULIN; TUMOR MARKER; WT1 PROTEIN;

ADENOCARCINOMA; ADENOMA; ADENOMATOID TUMOR; BENIGN TUMOR; CANCER DIAGNOSIS; CELL HYPERPLASIA; CONFERENCE PAPER; CYSTADENOMA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; EPITHELIUM TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MESOTHELIOMA; MESOTHELIUM; MESOTHELIUM CELL; MUELLERIAN DUCT; OVARY TUMOR; PERITONEUM MESOTHELIOMA; PLEURA MESOTHELIOMA; PLEURA METASTASIS; PRIORITY JOURNAL; RETE TESTIS; SENSITIVITY AND SPECIFICITY; SEROSA; TESTIS TUMOR; TUMOR LOCALIZATION; CELL PROLIFERATION; CHEMISTRY; EPITHELIUM; FEMALE; MALE; PATHOLOGY; PERITONEUM TUMOR; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; UTERUS CANCER;

CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; MICROSCOPY, ELECTRON, TRANSMISSION; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 33646010685     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913120500313200     Document Type: Conference Paper

References (88)

1. Comin C, de Klerk NH, Henderson DW. Malignant mesothelioma: current conundrums over risk estimates and whither electron microscopy for diagnosis? Ultrastruct Pathol. 1997;21:315-320.
2. Dardick I, Al-Jabi M, McCaughey WTE, et al. Ultrastructure of poorly differentiated diffuse epithelial mesotheliomas. Ultrastruct Pathol. 1984;7:151-160.
3. Hammar SP, Bockus DE, Remington FL, Rohrbach KA. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing adenocarcinomas. Ultrastruct Pathol. 1996;20:293-325.
4. Ordóñez NG, Mackay B. Electron microscopy in tumor diagnosis: indications for its use in the immunohistochemical era. Hum Pathol. 1998;29:1403-1411.
5. Oury TD, Hammar SP, Roggli VL. Ultrastructural features of diffuse malignant mesotheliomas. Hum Pathol. 1998;29:1382-1392.
6. Turbat-Herrera EA, Knowles K. Cytology: screening or diagnostic tool? Hum Pathol. 1998;29:1356-1366.
7. Brown RW, Clark GM, Tandon AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguish malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol. 1993;24:347-354.
8. Comin C, Novelli L, Boddi V, et al. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. Hum Pathol. 2001;32:529-536.
9. Han AC, Peralta-Soler A, Knudsen KA, et al. Differential expresión of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tisúes. Hum Pathol. 1997;28:641-645.
10. Khoor A, Whitsett JA, Stahlman MT, et al. Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol. 1999;30:695-700.
11. Ordóñez NG. The immunohistochemical diagnosis of mesothelioma: differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol. 1989;13:276-291.
12. Ordóñez NG. The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies. Am J Surg Pathol. 1997;21:1399-1408.
13. Ordóñez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol. 1998;22:1203-1214.
14. Ordóñez NG. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. Hum Pathol. 1998;29:166-169.
15. Ordóñez NG. The immunohistochemical diagnosis of epithelial mesothelioma. Hum Pathol. 1999;30:313-323.
16. Ordóñez NG. Immunohistochemical diagnosis of epithelioid mesotheliomas: a critical review of old markers, new markers. Hum Pathol. 2002;33:953-967.
17. Ordóñez NG. Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma. Hum Pathol. 2003;34:749-755.
18. Ordóñez NG. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study. Hum Pathol. 2004;35:697-710.
19. Riera JR, Astengo-Osuna C, Longmate JA, Battifora H. The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval. Am J Surg Pathol. 1997;21:1409-1419.
20. Robb JA. Mesothelioma versus adenocarcinoma: false-positive CEA and Leu-M1 staining due to hyaluronic acid. Hum Pathol. 1989;20:400.
21. Sheibani K. Increasing role of immunopathology in diagnosis of malignant mesothelioma. Hum Pathol. 1997;28:639-640.
22. Weiss LM, Battifora H. The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma. Hum Pathol. 1993;24:345-346.
23. Wick MR. Immunophenotyping of malignant mesothelioma. Am J Surg Pathol. 1997;21:1395-1398.
24. Donna A, Betta PG, Chiodera P, et al. Newly marketed tissue markers for malignant mesothelioma: immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies. Hum Pathol. 1997;28:929-937.
25. Chu AY, Litzky LA, Pasha TL, et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol. 2005;18:105-110.
26. Lloreta-Trull J, Ferrer L, Ribalta T, et al. Electron microscopy in pathology articles: a retrospective appraisal. Ultrastruct Pathol. 2000;24:105-108.
27. Hurlimann J. Desmin and neural marker expression in mesothelial cells and mesotheliomas. Hum Pathol. 1994;25:753-757.
28. Rosai J. Rosai and Ackerman's Surgical Pathology. Edinburgh: Mosby; 2004.
29. Khoury N, Raju U, Crissman JD, et al. A comparative immunohistochemical study of peritoneal and ovarian serous tumors, and mesotheliomas. Hum Pathol. 1990;21:811-819.
30. Raju U, Fine G, Greenawald KA, Ohorodnik JM. Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases. Hum Pathol. 1989;20:426-436.
31. Srigley JR. The paratesticular region: histoanatomic and general considerations. Semin Diagn Pathol. 2000;17:258-269.
32. Trainer TD. Testis and excretory duct system. In: Sternberg SS, ed. Histology for Pathologists. Philadelphia: Lippincott-Raven; 1997: 1019-1037.
33. Churg A, Colby TV, Cagle P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol. 2000;24:1183-1200.
34. Bolen JW, Hammar SP, McNutt MA. Reactive and neoplastic serosal tissue: a light-microscopic, ultrastructural, and immunocytochemical study. Am J Surg Pathol. 1986;10:34-47.
35. Kung ITM, Thallas V, Spencer EJ, Wilson SM. Expression of muscle actins in diffuse mesotheliomas. Hum Pathol. 1995;26:565-570.
36. Ordóñez NG, Ro JY, Ayala AG. Lesions described as nodular mesothelial hyperplasia are primarily composed of histiocytes. Am J Surg Pathol. 1998;22:285-292.
37. Rosai J, Dehner LP. Nodular mesothelial hyperplasia in hernia sacs: a benign reactive condition simulating a neoplastic process. Cancer. 1975;35:165-175.
38. Davis CJ, Sesterhenn IA, Woodward PJ. Tumours of paratesticular structures. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004:267-276.
39. Pérez-Ordóñez B, Srigley JR. Mesothelial lesions of the paratesticular region. Semin Diagn Pathol. 2000;17:294-306.
40. Sidhu GS, Fresko O. Adenomatoid tumor of the epididymis: ultrastructural evidence of its biphasic nature. Ultrastruct Pathol. 1980;1:39-47.
41. Srigley JR, Colgan TJ. Multifocal and diffuse adenomatoid tumor involving uterus and fallopian tube. Ultrastruct Pathol. 1988;12:351-355.
42. Raaf HN, Grant LD, Santoscoy C, et al. Adenomatoid tumor of the adrenal gland: a report of four new cases and a review of the literature. Mod Pathol. 1996;9:1046-1051.
43. Overstreet K, Wixom C, Shabaik A, et al. Adenomatoid tumor of the pancreas: a case report with comparison of histology and aspiration cytology. Mod Pathol. 2003;16:613-617.
44. Kaplan MA, Tazelaar HD, Hayashi T, Schroer KR, Travis WD. Adenomatoid tumors of the pleura. Am J Surg Pathol. 1996;20:1219-1223.
45. Natarajan S, Luthringer DJ, Fishbein MC. Adenomatoid tumor of the heart: report of a case. Am J Surg Pathol. 1997;21:1378-1380.
46. Mackay B, Bennington JL, Skoglund RW. The adenomatoid tumor: fine structural evidence for a mesothelial origin. Cancer. 1971;27:109-115.
47. Sawh RN, Malpica A, Deavers MT, Liu J, Silva EG. Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status. Hum Pathol. 2003;34:369-374.
48. Nistal M, Mate A, Paniagua R. Cystic transformation of the rete testis. Am J Surg Pathol. 1996;20:1231-1239.
49. Marshall RM, Gould VE, King ME, et al. Multicystic abdominal peritoneal tumor presenting as an enlarging incisional hernia. Ultrastruct Pathol. 1985;8:249-256.
50. Ulbright TM. Neoplasms of the testis. In: Bostwick DG, Eble JN, eds. Urologic Surgical Pathology. St. Louis: Mosby; 1997:567-645.
51. Henley JD, Ferry J, Ulbright TM. Miscellaneous rare paratesticular tumors. Semin Diagn Pathol. 2000;17:319-339.
52. Jones EC, Murray SK, Young RH. Cysts and epithelial proliferations of the testicular collecting system (including rete testis). Semin Diagn Pathol. 2000;17:270-293.
53. Bostwick DG. Spermatic cord and testicular adnexa. In: Bostwick DG, Eble JN, eds. Urologic Surgical Pathology. St. Louis: Mosby; 1997:647-671.
54. Andrion A, Bosia S, Paoletti L, et al. Malignant peritoneal mesothelioma in a 17-year-old boy with evidence of previous exposure to chrysotile and tremolite asbestos. Hum Pathol. 1994;25:617-622.
55. Attanoos RL, Gibbs AR. Primary malignant gonadal mesotheliomas and asbestos. Histopathology. 2000;37:150-159.
56. Eyden BP, Banik S, Harris M. Malignant epithelial mesothelioma of the peritoneum: observations on a problem case. Ultrastruct Pathol. 1996;20:337-344.
57. Talerman A, Chilcote RR, Montero JR, Okagaki T. Diffuse malignant peritoneal mesothelioma in a 13-year-old girl: report of a case and review of the literature. Am J Surg Pathol. 1985;9:73-80.
58. Clement PB, Young RH, Scully RE. Malignant mesotheliomas presenting as ovarian masses: a report of nine cases, including two primary ovarian mesotheliomas. Am J Surg Pathol. 1996;20:1067-1080.
59. Shimazaki H, Aida S, Iizuka Y, et al. Vacuolated cell mesothelioma of the pericardium resembling liposarcoma: a case report. Hum Pathol. 2000;31:767-770.
60. Chang HT, Yantiss RK, Nielsen GP, et al. Lipid-rich diffuse malignant mesothelioma: a case report. Hum Pathol. 2000;31:876-879.
61. Ordóñez NG, Mackay B. Glycogen-rich mesothelioma. Ultrastruct Pathol. 1999;23:401-406.
62. Flint A, Weiss SW. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Hum Pathol. 1995;26:428-431.
63. Klima M, Bossart MI. Sarcomatous type of malignant mesothelioma. Ultrastruct Pathol. 1983;4:349-358.
64. Shanks JH, Harris M, Banerjee SS, Eyden BP, et al. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females. Am J Surg Pathol. 2000;24:285-294.
65. Shia J, Erlandson RA, Klimstra DS. Deciduoid mesothelioma: a report of 5 cases and literature review. Ultrastruct Pathol. 2002;26:355-363.
66. Khalidi HS, Medeiros J, Battifora H. Lymphohistiocytoid mesothelioma. Am J Clin Pathol. 2000;113:649-654.
67. Mayall FG, Goddard H, Gibbs AR. Intermediate filament expression in mesotheliomas. Leiomyoid mesotheliomas are not uncommon. Histopathology. 1992;21:453-457.
68. Jones MA, Young RH, Scully RE. Malignant mesothelioma of the tunica vaginalis: a clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol. 1995;19:815-825.
69. Masangkay AV, Susin M, Baker R, et al. Metastatic malignant mesothelioma presenting as colonic polyps. Hum Pathol. 1997;28:993-995.
70. Shah IA, Somsin A, Wong SX, et al. Malignant mesothelioma presenting as colonic tumor. Hum Pathol 1998;29:657.
71. Prat J. Pathology of the Ovary. Philadelphia: Saunders; 2004.
72. Soslow RA, Pirog E, Isacson C. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am J Surg Pathol. 2000;24:726-732.
73. Baker PM, Oliva E. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol. 2005;24:39-55.
74. Acs G, Pasha T, Zhang PJ. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol. 2004;23:110-118.
75. Hwang H. Quenneville L, Yaziji H, Gown AM. Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin. Appl Immunohistochem Mol Morphol. 2004;12:122-126.
76. Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology. 2002;40:237-244.
77. Wauters CC, Smedts F, Gerrits LG, Bosman FT, Ramaekers FC. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol. 1995;26:852-855.
78. Cibas ES, Corson JM, Pinkus GS. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epitelial membrane antigen, and milk fat globule-derived antigen. Hum Pathol. 1987;18:67-74.
79. Fenoglio CM. Ultrastructural features of the common epithelial tumors of the ovary. Ultrastruct Pathol. 1980;1:419-444.
80. Ghadially FN, Rippstein PU, Cavell S, Venance SL. Giant desmosomes in tumors. Ultrastruct Pathol. 1995;19:469-474.
81. Posalaky Z, McGinley D. Occluding junctions in an epithelioid mesothelioma: a freeze-fracture study. Ultrastruct Pathol. 1984;6:177-183.
82. Jones MA, Young RH, Srigley JR, Scully RE. Paratesticular serous papillary carcinoma: a report of six cases. Am J Surg Pathol. 1995;19:1359-1365.
83. Weir MM, Bell DA, Young RH. Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors. Am J Surg Pathol. 1998;22:849-862.
84. Truong LD, Maccato ML, Awalt H, et al. Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases. Hum Pathol. 1990;21:99-110.
85. Nochomovitz L. Tumours of collecting ducts and rete. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004:265-266.
86. Nochomovitz LE, Orenstein JM. Adenocarcinoma of the rete testis: review and reagrupping of reported cases and a consideration of miscellaneous entities. J Urogenithal Path. 1991;1:11-40.
87. Skailes GE, Menasce L, Banerjee SS, et al. Adenocarcinoma of the rete testis. Clin Oncol (R Coll Radiol). 1998;10:401-403.
88. Mrak RE, Hussain MM, Schaefer RF. Ultrastructure of metastatic rete testis adenocarcinoma. Arch Pathol Lab Med. 1990;114:84-88.